Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey C La Rochelle

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Urology|November 18, 2011
Urological manifestations of sarcoidosisJeffrey C La Rochelle, Christopher L Coogan
The Urologic Clinics of North America|November 3, 2011
Role of lymphadenectomy for prostate cancer: indications and controversiesJeffrey C La Rochelle, Christopher L Amling
Urology|February 15, 2005
Is routine postoperative chest radiography needed after open nephrectomy?Kalyan C Latchamsetty, Jeffrey C La Rochelle, Jerome Hoeksema, et al.
The Journal of Urology|November 5, 2013
Timing, incidence and risk factors for venous thromboembolism in patients undergoing radical cystectomy for malignancy: a case for extended duration pharmacological prophylaxisAmanda A VanDlac, Nick G Cowan, Yiyi Chen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Urology|November 18, 2011
Urological manifestations of sarcoidosisJeffrey C La Rochelle, Christopher L Coogan
The Urologic Clinics of North America|November 3, 2011
Role of lymphadenectomy for prostate cancer: indications and controversiesJeffrey C La Rochelle, Christopher L Amling
Urology|February 15, 2005
Is routine postoperative chest radiography needed after open nephrectomy?Kalyan C Latchamsetty, Jeffrey C La Rochelle, Jerome Hoeksema, et al.
The Journal of Urology|November 5, 2013
Timing, incidence and risk factors for venous thromboembolism in patients undergoing radical cystectomy for malignancy: a case for extended duration pharmacological prophylaxisAmanda A VanDlac, Nick G Cowan, Yiyi Chen, et al.
Pageof 1